Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2003 14
2004 9
2005 10
2006 7
2007 17
2008 10
2009 2
2010 15
2011 13
2012 16
2013 22
2014 10
2015 15
2016 22
2017 21
2018 35
2019 34
2020 39
2021 39
2022 34
2023 48
2024 48

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

430 results

Results by year

Filters applied: . Clear all
Page 1
Lichen Simplex Chronicus Itch: An Update.
Ju T, Vander Does A, Mohsin N, Yosipovitch G. Ju T, et al. Among authors: yosipovitch g. Acta Derm Venereol. 2022 Oct 19;102:adv00796. doi: 10.2340/actadv.v102.4367. Acta Derm Venereol. 2022. PMID: 36250769 Free PMC article.
Immunotargets and Therapy for Prurigo Nodularis.
Labib A, Ju T, Vander Does A, Yosipovitch G. Labib A, et al. Among authors: yosipovitch g. Immunotargets Ther. 2022 Apr 26;11:11-21. doi: 10.2147/ITT.S316602. eCollection 2022. Immunotargets Ther. 2022. PMID: 35502157 Free PMC article. Review.
Transient Receptor Potential Channels and Itch.
Mahmoud O, Soares GB, Yosipovitch G. Mahmoud O, et al. Among authors: yosipovitch g. Int J Mol Sci. 2022 Dec 27;24(1):420. doi: 10.3390/ijms24010420. Int J Mol Sci. 2022. PMID: 36613861 Free PMC article. Review.
Skin changes in the obese patient.
Hirt PA, Castillo DE, Yosipovitch G, Keri JE. Hirt PA, et al. Among authors: yosipovitch g. J Am Acad Dermatol. 2019 Nov;81(5):1037-1057. doi: 10.1016/j.jaad.2018.12.070. J Am Acad Dermatol. 2019. PMID: 31610857 Review.
Pruritus in Keloid Scars: Mechanisms and Treatments.
Hawash AA, Ingrasci G, Nouri K, Yosipovitch G. Hawash AA, et al. Among authors: yosipovitch g. Acta Derm Venereol. 2021 Oct 28;101(10):adv00582. doi: 10.2340/00015555-3923. Acta Derm Venereol. 2021. PMID: 34518894 Free PMC article. Review.
Chronic Pruritus: A Review.
Butler DC, Berger T, Elmariah S, Kim B, Chisolm S, Kwatra SG, Mollanazar N, Yosipovitch G. Butler DC, et al. Among authors: yosipovitch g. JAMA. 2024 Jun 25;331(24):2114-2124. doi: 10.1001/jama.2024.4899. JAMA. 2024. PMID: 38809527 Review.
Itch: From mechanism to (novel) therapeutic approaches.
Yosipovitch G, Rosen JD, Hashimoto T. Yosipovitch G, et al. J Allergy Clin Immunol. 2018 Nov;142(5):1375-1390. doi: 10.1016/j.jaci.2018.09.005. J Allergy Clin Immunol. 2018. PMID: 30409247 Review.
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Simpson EL, Sinclair R, Forman S, Wollenberg A, Aschoff R, Cork M, Bieber T, Thyssen JP, Yosipovitch G, Flohr C, Magnolo N, Maari C, Feeney C, Biswas P, Tatulych S, Valdez H, Rojo R. Simpson EL, et al. Among authors: yosipovitch g. Lancet. 2020 Jul 25;396(10246):255-266. doi: 10.1016/S0140-6736(20)30732-7. Lancet. 2020. PMID: 32711801 Free article. Clinical Trial.
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
Kwatra SG, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Lynde C, De Bruin-Weller MS, Nahm WK, Sauder M, Gharib R, Barbarot S, Szepietowski JC, Conrad C, Fleischer A, Laquer VT, Misery L, Serra-Baldrich E, Lapeere H, Ahmad F, Jabbar Lopez ZK, Piketty C, Ständer S; OLYMPIA 2 Investigators. Kwatra SG, et al. Among authors: yosipovitch g. N Engl J Med. 2023 Oct 26;389(17):1579-1589. doi: 10.1056/NEJMoa2301333. N Engl J Med. 2023. PMID: 37888917 Clinical Trial.
430 results